High dosages of anti-VEGFs can cause systemic complications like decreased serum VEGF levels, myocardial infarction, CNS hemorrhage, and ocular complications such as tears in the retinal pigment epithelium, retinal detachment, and geographic atrophy [20]. The gene discussed is VEGFA; the disease is retinal detachment.